Caveolin-induced activation of the phosphatidylinositol 3-kinase/Akt pathway increases arsenite cytotoxicity

Molecular and Cellular Biology

Volumn 23, Issue 7, 2003, Pages 2407-2414

  Shack, Sonsoles ^a   Wang, Xian Tao ^a   Kokkonen, Gertrude C ^a   Gorospe, Myriam ^a   Longo, Dan L ^a   Holbrook, Nikki J ^a,b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENITE SODIUM; CAVEOLIN; CERAMIDE; HYDROGEN PEROXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SPHINGOMYELIN PHOSPHODIESTERASE; WORTMANNIN;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME ACTIVITY; HELA CELL; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ARSENITES; BLOTTING, WESTERN; CAVEOLIN 1; CAVEOLINS; CELL LINE; CELL SURVIVAL; CERAMIDES; ENZYME ACTIVATION; ENZYME INHIBITORS; FIBROBLASTS; GENES, DOMINANT; HELA CELLS; HUMANS; OXIDANTS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 0037379438     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.7.2407-2414.2003     Document Type: Article

References (44)

1. Alessandrini, A., S. Namura, M. A. Molkowitz, and J. V. Bonaventre. 1999. MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc. Natl. Acad. Sci. USA 96:12866-12869.
2. Anderson, R. G. W. 1998. The caveolae membrane system. Annu. Rev. Biochem. 67:199-225.
3. Arcaro, A., and M. P. Wymann. 1993. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem. J. 296:297-301.
4. Bagla, P., and J. Kaiser. 1996. India's spreading health crisis draws global arsenic experts. Science 274:174-175.
5. Barchowsky, A., E. J. Dudek M. D. Treadwell, and K. E. Wetterhan. 1996. Arsenic induces oxidant stress and NF-kappa B activation in cultured aortic endothelial cells. Free Radic. Biol. Med. 21:783-790.
6. Carpenter, G. 1999. Employment of the epidermal growth factor receptor in growth factor-independent signalling pathways. J. Cell Biol. 146:697-702.
7. Chang, L., and M. Karin. 2001. Mammalian MAP kinase signalling cascades. Nature 410:37-40.
8. Chen, W., J. L. Martindale, N. J. Holbrook, and Y. Liu. 1998. Tumor promoter arsenite activates extracellular signal-regulated kinase through a signaling pathway mediated by epidermal growth factor receptor and Shc. Mol. Cell. Biol. 18:5178-5188.
9. Datta, S. R., A. Brunet, and M. E. Greenberg. 1999. Cellular survival: a play in three Akts. Genes Dev. 13:2905-2927.
10. Engelman, J. A., C. Chu, A. Lin, H. Jo, T. Ikezu, T. Okamoto, D. S. Kohtz, and M. P. Lisanti. 1998. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett. 428:205-211.
11. Galbiatti, F., D. Volonte, J. A. Engelman, G. Watanabe, R. Burk, R. G. Pestell, and M. P. Lisanti. 1998. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J. 17:6633-6648.
12. Guyton, K. Z., M. Gorospe, X. Wang, Y. D. Mock, G. C. Kokkonen, Y. Liu, G. S. Roth, and N. J. Holbrook. 1998. Age-related changes in activation of mitogen-activated protein kinase cascades by oxidative stress. J. Investig. Dermatol. Symp. Proc. 3:23-27.
13. Ikeyama, S., G. Kokkonen, S. Shack, X. T. Wang, and N. J. Holbrook. 2002. Loss in oxidative stress tolerance with aging linked to reduced extracellular signal-regulated kinase and Akt kinase activities. FASEB J. 16:114-116.
14. Kenyon, E. M., and M. F. Hughes. 2001. A concise review of the toxicity and carcinogenicity of dimethylarsinic acid. Toxicology 160:227-236.
15. Koleske, A. J., D. Baltimore, and M. P. Lisanti. 1995. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc. Natl. Acad. Sci. USA 92:1381-1385.
16. Liu, J., P. Oh, T. Horner, R. A. Rogers, and J. E. Schnitzer. 1997. Organized endothelial cell surface signal transduction in caveolae distinct from glycosylphosphatidylinositol-anchored protein microdomains. J. Biol. Chem. 272: 7211-7222.
17. Liu, J., P. Lee, F. Galbiati, R. N. Kitsis, and M. P. Lisanti. 2001. Caveolin-1 expression sensitizes fibroblastic and epithelial cells to apoptotic stimulation. Am. J. Cell Physiol. 280:C823-C835.
18. Liu, P., and R. G. W. Anderson. 1995. Compartmentalized production of ceramide at the cell surface. J. Biol. Chem. 270:27179-27185.
19. Liu, P., Y. Ying, Y. G. Ko, and R. G. Anderson. 1996. Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae. J. Biol. Chem. 271:299-310.
20. 2+-dependent enzyme and role of isoprenoid chain. Biochem. Biophys. Res. Commun. 297:581-586.
21. Martindale, J. L., and N. J. Holbrook. 2002. Cellular response to oxidative stress: signaling for suicide and survival. J. Cell. Physiol. 192:1-15.
22. Nemoto, S., and T. Finkel. 2002. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 295:2450-2452.
23. Okamoto, T., A. Schlegel, P. E. Scherer, and M. P. Lisanti. 1998. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J. Biol. Chem. 273:5419-5422.
24. Palade, G. E., and R. R. Bruns. 1968. Structural modification of plasmalemma vesicles. J. Cell Biol. 37:633-649.
25. Park, S. A., H. J. Park, B. I. Lee, Y. H. Ahn, S. U. Kim, and K. S. Choi. 2001. Bcl-2 blocks cisplatin-induced apoptosis by suppression of ERK-mediated p53 accumulation in B104 cells. Brain Res. Mol. Brain Res. 93:18-26.
26. Park, W. Y., J. S. Park, K. A. Cho, D. I. Kim, Y. G. Ko, J. S. Seo, and S. C. Park. 2000. Up-regulation of caveolin attenuates epidermal growth factor signaling in senescent cells. J. Biol. Chem. 275:20847-20852.
27. Razani, B., A. Schlegel, J. Liu, and M. P. Lisanti. 2001. Caveolin-1, a putative tumour suppressor gene. Biochem. Soc. Trans. 29:494-499.
28. Rothberg, K. G., J. E. Heuser, W. C. Donzell, Y. S. Ying, J. R. Glenney, and R. G. Anderson. 1992. Caveolin, a protein component of caveolae membrane coats. Cell 68:673-682.
29. Sargiacomo, M., P. E. Scherer, Z. L. Tang, E. Kubler, K. S. Song, M. C. Sanders, and M. P. Lisanti. 1995. Oligomeric structure of caveolin: implications for caveolin membrane organization. Proc. Natl. Acad. Sci. USA 92:9407-9411.
30. Schlegel, A., and M. P. Lisanti. 2001. Caveolae and their coat proteins, the caveolins: from electron microscopic novelty to biological launching pad. J. Cell. Physiol. 186:329-337.
31. Shaul, P. W., and R. G. Anderson. 1998. Role of plasmalemmal caveolae in signal transduction. Am. J. Physiol. 275:L843-L851.
32. Smart, E. J., G. A. Graf, M. A. McNiven, W. C. Sessa, F. A. Engelman, P. E. Scherer, T. Okamoto, and M. P. Lisanti. 1999. Caveolins, liquid-ordered domains, and signal transduction. Mol. Cell. Biol. 19:7289-7304.
33. Song, K. S., Z. L. Tang, S. Li, and M. P. Lisanti. 1997. Mutational analysis of the properties of caveolin-1. A novel role for the C-terminal domain in mediating homo-typic caveolin-caveolin interactions. J. Biol Chem. 272:4398-4403.
34. Sutherland, C. L., A. W. Heath, S. L. Pelech, P. R. Young, and M. R. Gold. 1996. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor. J. Immunol. 157:3381-3390.
35. Tomiuk, S., M. Zumbansen, and W. Stoffel. 2000. Characterization and subcellular localization of murine and human magnesium-dependent neutral sphingomyelinase. J. Biol. Chem. 275:5710-5717.
36. Veldman, R. J., N. Maestre, O. M. Abduib, J. A. Medin, R. Salvayre, and T. Levade. 2001. A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour necrosís factor signalling. Biochem. J. 355:859-868.
37. Vlahos, C. J., W. F. Matter, K. Y. Hui, and R. F. Brown. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H1benzopyran-4-one (LY294002). J. Biol. Chem. 269:5241-5248.
38. Wang, X., J. L. Martindale, Y. Liu, and N. J. Holbrook. 1998. The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem. J. 333:291-300.
39. Wang, X., K. D. McCullough, T. F. Franke, and N. J. Holbrook. 2000. Epidermal growth factor receptor-dependent Akt activation by oxidative stress enhances cell survival. J. Biol. Chem. 275:14624-14631.
40. Wang,X., J. L. Martindale, and N. J. Holbrook. 2000. Requirement for ERK activation in cisplatin-induced apoptosis. J. Biol. Chem. 275:39435-39443.
41. Yamada, E. 1955. The fine structure of the gall bladder epithelium of the mouse. J. Biophys. Biochem. Cytol. 1:445-458.
42. Yu, W., J. Cassara, and P. F. Weller. 2000. Phosphatidylinositide 3-kinase localizes to cytoplasmic lipid bodies in human polymorphonuclear leukocytes and other myeloid-derived cells. Blood 95:1078-1085.
43. Zundel, W., and A. Giaccia. 1998. Inhibition of the antiapoptotic PI(3)K/ Akt/Bad pathway by stress. Genes Dev. 12:1941-1946.
44. Zundel, W., L. M. Swiersz and A. Giaccia. 2000. Caveolin 1-mediated regulation of receptor tyrosine kinase-associated phosphatidylinositol 3-kinase activity by ceramide. Mol. Cell. Biol. 20:1507-1514.